Global Histopathology Services Market By Service Type (Tissue processing, Staining, Immunohistochemistry, Pathology Evaluation, Slide Preparation and Evaluation, Others) By End Users (Research Centers, Hospitals and Clinics, Pharmaceutical Companies, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Pathology is still mainly done through microscopic assessment of stained tissue specimens mounted on glass slides, notwithstanding the broad adoption of digitization in clinical and preclinical procedures. Digital pathology has emerged as a result of recent technology advancements, such as the increased popularity of histology slide digitization and the availability of high-powered computational resources. New high-throughput digital scanning microscopes, together with recent breakthroughs in machine vision, have ushered in a new era of digital pathology, which has opened up new possibilities for computer-aided-diagnosis. While much of the initial reason for slide digitization probably stems from research and development efforts aimed at, for example, machine learning-assisted diagnosis, recent advances in imaging technologies, as well as image reconstruction and transformation algorithms, have opened up new possibilities that have the potential to change the landscape of how histopathology is practised. Moreover for several years, pathologists and histotechnologists have been fascinated by a new generation of tissue processors and technological advancements. Faster turnaround times requested by physicians eager to make diagnoses and begin treatments, as well as improved capabilities of the histology laboratory and surgical pathology areas resulting from new types of equipment, will be among the changes in histopathology laboratories over the next few years. Histology laboratories at different hospitals are collaborating to standardise their techniques in order for these new tests to be approved by the medical community. Thus, with the above factors the histopathology services market is experiencing tremendous growth globally.
The covid-19 pandemic of severe acute respiratory syndrome has wreaked havoc on global health and the global economy. Despite initial concerns about doing autopsies due to the threat of viral particles being volatilized, a slew of autopsy studies released since May 2020 have given information on the Covid-19 virus. Specifically, cytological and histopathological methods, as well as autoptic results, were important tools for better understanding illness and accurately defining causes of death. During the pandemic various government organizations across globe were investing into training of histopathology services and recruitment of more histopathology staff. Thus due to Covid-19, the demand for histopathology services market has augmented considerably.
In terms of revenue, the global histopathology services market is anticipated to grow at a CAGR of 5.8% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Histopathology Services Market Revenue & Forecast, (US$ Million), 2015 – 2029
Services Outlook:
Based on the service type, the global histopathology services market is segmented into tissue processing, staining, immunohistochemistry, pathology evaluation, slide preparation and evaluation, others. Histopathology services companies are looking forward to provide extensive services by highly skilled and experienced histopathologists as consultants. Immunohistochemistry is one amongst the numerous services gaining huge popularity in the global histopathology services market as there is a rising prelevance of various cancers and brain tumors. Immunohistochemistry is used to quantify protein expression and localisation inside tissues and has long been employed in research and diagnostic laboratories. Immunohistochemical labelling is widely employed in diagnosis and basic research, to comprehend the distribution and localization of biomarkers and differentially expressed proteins in distinct areas of a biological tissue. Furthermore, large pharmaceutical companies are looking forward to outsourcing histopathology services for standard and efficient results which is boosting the global histopathology services market.
End Users Outlook:
Based on end users segment, the global histopathology services market is segmented into research centers, hospitals and clinics, pharmaceutical companies and others. Research centers and pharmaceutical companies are looking forward to introducing new medicines and therapies for various diseases. Market participants are looking forward to mergers and acquisitions. For instance, in 2019, StageBio and Alizée Pathology have united to establish the industry's foremost provider of specialised histology, pathology, biomarker discovery, and archiving services for the biopharmaceutical, medical device, and contract research industries. Thus such mergers will offer StageBio to provide a wider range of highly specialised histology and imaging services to business.
Region Outlook:
Based on the regions, North America has the highest share in the global histopathology services market. The market for histopathology services in North America is rising as the number of surgical procedures have increased, the rise in elderly population and change in lifestyle, resulting in life-threatening illnesses. These factors have led to huge investments in technologies such as the incorporation of AI in histopathology which has a huge amount of potential, since it will allow pathologists to quickly deliver diagnoses for patients in an objective and time-saving manner. Moreover the companies are expanding their presence across North America, for instance, StageBio opened their new facility close to the biotechnology and medical research centers of Cambridge and Boston to expand their local offering which includes a comprehensive list of specific stains, immunohistochemistry, and immunofluorescence, as well as the ability to run experiments on a number of instruments and chemicals. Thus the histopathology services market in North America is on the rise.
Competitive Landscape
The report provides both, qualitative and quantitative research of histopathology services market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the histopathology services market are:
- AnaPath Services Gmbh
- BioIVT LLC.
- CellCarta
- Cellular Pathology Services Limited
- Comparative Biosciences, Inc.
- Core Diagnostics, HistologiX Limited
- Histopathology Services Inc.
- Liveon Biolabs Pvt.Ltd.
- MLM Medical Labs GmbH
- Molecular Diagnostic Services, Inc.
- Pathology Services Core
- Q2 Solutions
- Saffron Scientific Histology Services
- Suburban Diagnostics
- The Doctors Laboratory
- TOXIKON
- Other Market Participants
Global Histopathology Services Market
By Service Type
- Tissue processing
- Staining
- Immunohistochemistry
- Pathology evaluation
- Slide preparation and evaluation
- Others
By End-User
- Research Centers
- Hospitals and Clinics
- Pharmaceutical Companies
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Histopathology Services Market
6.
Market
Synopsis: Histopathology Services Market
7.
Histopathology
Services Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Histopathology Services Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Histopathology Services Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Histopathology Services
Market
8.
Global
Histopathology Services Market Analysis and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global Histopathology Services Market Revenue
(US$ Mn)
8.2. Global Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
8.2.1. Tissue processing
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.1.3.
Market
Forecast, 2021 - 2029
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1.
Market
Estimation, 2015 - 2020
8.2.1.5.1.2.
Market
Forecast, 2021 - 2029
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market
Estimation, 2015 - 2020
8.2.1.5.2.2.
Market
Forecast, 2021 - 2029
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1.
Market
Estimation, 2015 - 2020
8.2.1.5.3.2.
Market
Forecast, 2021 - 2029
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1.
Market
Estimation, 2015 - 2020
8.2.1.5.4.2.
Market
Forecast, 2021 - 2029
8.2.1.5.5.
Latin
America
8.2.1.5.5.1.
Market
Estimation, 2015 - 2020
8.2.1.5.5.2.
Market
Forecast, 2021 - 2029
8.2.2. Staining
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.2.3.
Market
Forecast, 2021 - 2029
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1.
Market
Estimation, 2015 - 2020
8.2.2.5.1.2.
Market
Forecast, 2021 - 2029
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market
Estimation, 2015 - 2020
8.2.2.5.2.2.
Market
Forecast, 2021 - 2029
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1.
Market
Estimation, 2015 - 2020
8.2.2.5.3.2.
Market
Forecast, 2021 - 2029
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1.
Market
Estimation, 2015 - 2020
8.2.2.5.4.2.
Market
Forecast, 2021 - 2029
8.2.2.5.5.
Latin
America
8.2.2.5.5.1.
Market
Estimation, 2015 - 2020
8.2.2.5.5.2.
Market
Forecast, 2021 - 2029
8.2.3. Immunohistochemistry
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.3.3.
Market
Forecast, 2021 - 2029
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1.
Market
Estimation, 2015 - 2020
8.2.3.5.1.2.
Market
Forecast, 2021 - 2029
8.2.3.5.2.
Europe
8.2.3.5.2.1.
Market
Estimation, 2015 - 2020
8.2.3.5.2.2.
Market
Forecast, 2021 - 2029
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1.
Market
Estimation, 2015 - 2020
8.2.3.5.3.2.
Market
Forecast, 2021 - 2029
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1.
Market
Estimation, 2015 - 2020
8.2.3.5.4.2.
Market
Forecast, 2021 - 2029
8.2.3.5.5.
Latin
America
8.2.3.5.5.1.
Market
Estimation, 2015 - 2020
8.2.3.5.5.2.
Market
Forecast, 2021 - 2029
8.2.4. Pathology evaluation
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.4.3.
Market
Forecast, 2021 - 2029
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1.
Market
Estimation, 2015 - 2020
8.2.4.5.1.2.
Market
Forecast, 2021 - 2029
8.2.4.5.2.
Europe
8.2.4.5.2.1.
Market
Estimation, 2015 - 2020
8.2.4.5.2.2.
Market
Forecast, 2021 - 2029
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1.
Market
Estimation, 2015 - 2020
8.2.4.5.3.2.
Market
Forecast, 2021 - 2029
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1.
Market
Estimation, 2015 - 2020
8.2.4.5.4.2.
Market
Forecast, 2021 - 2029
8.2.4.5.5.
Latin
America
8.2.4.5.5.1.
Market
Estimation, 2015 - 2020
8.2.4.5.5.2.
Market
Forecast, 2021 - 2029
8.2.5. Slide preparation and evaluation
8.2.5.1.
Definition
8.2.5.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.5.3.
Market
Forecast, 2021 - 2029
8.2.5.4.
Compound
Annual Growth Rate (CAGR)
8.2.5.5.
Regional
Bifurcation
8.2.5.5.1.
North
America
8.2.5.5.1.1.
Market
Estimation, 2015 - 2020
8.2.5.5.1.2.
Market
Forecast, 2021 - 2029
8.2.5.5.2.
Europe
8.2.5.5.2.1.
Market
Estimation, 2015 - 2020
8.2.5.5.2.2.
Market
Forecast, 2021 - 2029
8.2.5.5.3.
Asia
Pacific
8.2.5.5.3.1.
Market
Estimation, 2015 - 2020
8.2.5.5.3.2.
Market
Forecast, 2021 - 2029
8.2.5.5.4.
Middle
East and Africa
8.2.5.5.4.1.
Market
Estimation, 2015 - 2020
8.2.5.5.4.2.
Market
Forecast, 2021 - 2029
8.2.5.5.5.
Latin
America
8.2.5.5.5.1.
Market
Estimation, 2015 - 2020
8.2.5.5.5.2.
Market
Forecast, 2021 - 2029
8.2.6. Others
8.2.6.1.
Definition
8.2.6.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.6.3.
Market
Forecast, 2021 - 2029
8.2.6.4.
Compound
Annual Growth Rate (CAGR)
8.2.6.5.
Regional
Bifurcation
8.2.6.5.1.
North
America
8.2.6.5.1.1.
Market
Estimation, 2015 - 2020
8.2.6.5.1.2.
Market
Forecast, 2021 - 2029
8.2.6.5.2.
Europe
8.2.6.5.2.1.
Market
Estimation, 2015 - 2020
8.2.6.5.2.2.
Market
Forecast, 2021 - 2029
8.2.6.5.3.
Asia
Pacific
8.2.6.5.3.1.
Market
Estimation, 2015 - 2020
8.2.6.5.3.2.
Market
Forecast, 2021 - 2029
8.2.6.5.4.
Middle
East and Africa
8.2.6.5.4.1.
Market
Estimation, 2015 - 2020
8.2.6.5.4.2.
Market
Forecast, 2021 - 2029
8.2.6.5.5.
Latin
America
8.2.6.5.5.1.
Market
Estimation, 2015 - 2020
8.2.6.5.5.2.
Market
Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Service Type
9.
Global
Histopathology Services Market Analysis and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
9.2.1. Research Centers
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.1.3.
Market
Forecast, 2021 - 2029
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1.
Market
Estimation, 2015 - 2020
9.2.1.5.1.2.
Market
Forecast, 2021 - 2029
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market
Estimation, 2015 - 2020
9.2.1.5.2.2.
Market
Forecast, 2021 - 2029
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1.
Market
Estimation, 2015 - 2020
9.2.1.5.3.2.
Market
Forecast, 2021 - 2029
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1.
Market
Estimation, 2015 - 2020
9.2.1.5.4.2.
Market
Forecast, 2021 - 2029
9.2.1.5.5.
Latin
America
9.2.1.5.5.1.
Market
Estimation, 2015 - 2020
9.2.1.5.5.2.
Market
Forecast, 2021 - 2029
9.2.2. Hospitals and Clinics
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.2.3.
Market
Forecast, 2021 - 2029
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1.
Market
Estimation, 2015 - 2020
9.2.2.5.1.2.
Market
Forecast, 2021 - 2029
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market
Estimation, 2015 - 2020
9.2.2.5.2.2.
Market
Forecast, 2021 - 2029
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1.
Market
Estimation, 2015 - 2020
9.2.2.5.3.2.
Market
Forecast, 2021 - 2029
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1.
Market
Estimation, 2015 - 2020
9.2.2.5.4.2.
Market
Forecast, 2021 - 2029
9.2.2.5.5.
Latin
America
9.2.2.5.5.1.
Market
Estimation, 2015 - 2020
9.2.2.5.5.2.
Market
Forecast, 2021 - 2029
9.2.3. Pharmaceutical Companies
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.3.3.
Market
Forecast, 2021 - 2029
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1.
Market
Estimation, 2015 - 2020
9.2.3.5.1.2.
Market
Forecast, 2021 - 2029
9.2.3.5.2.
Europe
9.2.3.5.2.1.
Market
Estimation, 2015 - 2020
9.2.3.5.2.2.
Market
Forecast, 2021 - 2029
9.2.3.5.3.
Asia Pacific
9.2.3.5.3.1.
Market
Estimation, 2015 - 2020
9.2.3.5.3.2.
Market
Forecast, 2021 - 2029
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1.
Market
Estimation, 2015 - 2020
9.2.3.5.4.2.
Market
Forecast, 2021 - 2029
9.2.3.5.5.
Latin
America
9.2.3.5.5.1.
Market
Estimation, 2015 - 2020
9.2.3.5.5.2.
Market
Forecast, 2021 - 2029
9.2.4. Others
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.4.3.
Market
Forecast, 2021 - 2029
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1.
Market
Estimation, 2015 - 2020
9.2.4.5.1.2.
Market
Forecast, 2021 - 2029
9.2.4.5.2.
Europe
9.2.4.5.2.1.
Market
Estimation, 2015 - 2020
9.2.4.5.2.2.
Market
Forecast, 2021 - 2029
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1.
Market
Estimation, 2015 - 2020
9.2.4.5.3.2.
Market
Forecast, 2021 - 2029
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1.
Market
Estimation, 2015 - 2020
9.2.4.5.4.2.
Market
Forecast, 2021 - 2029
9.2.4.5.5.
Latin
America
9.2.4.5.5.1.
Market
Estimation, 2015 - 2020
9.2.4.5.5.2.
Market
Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By End Users
10. North America Histopathology Services Market
Analysis and Forecasts, 2021 - 2029
10.1. Overview
10.1.1. North America Histopathology Services Market
Revenue (US$ Mn)
10.2. North America Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
10.2.1. Tissue processing
10.2.2. Staining
10.2.3. Immunohistochemistry
10.2.4. Pathology evaluation
10.2.5. Slide preparation and evaluation
10.2.6. Others
10.3. North America Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
10.3.1. Research Centers
10.3.2. Hospitals and Clinics
10.3.3. Pharmaceutical Companies
10.3.4. Others
10.4. North America Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
10.4.1.1.1. Tissue processing
10.4.1.1.2. Staining
10.4.1.1.3. Immunohistochemistry
10.4.1.1.4. Pathology evaluation
10.4.1.1.5. Slide preparation and evaluation
10.4.1.1.6. Others
10.4.1.2. U.S Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
10.4.1.2.1. Research Centers
10.4.1.2.2. Hospitals and Clinics
10.4.1.2.3. Pharmaceutical Companies
10.4.1.2.4. Others
10.4.2. Canada
10.4.2.1. Canada Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
10.4.2.1.1. Tissue processing
10.4.2.1.2. Staining
10.4.2.1.3. Immunohistochemistry
10.4.2.1.4. Pathology evaluation
10.4.2.1.5. Slide preparation and evaluation
10.4.2.1.6. Others
10.4.2.2. Canada Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
10.4.2.2.1. Research Centers
10.4.2.2.2. Hospitals and Clinics
10.4.2.2.3. Pharmaceutical Companies
10.4.2.2.4. Others
10.4.3. Mexico
10.4.3.1. Mexico Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
10.4.3.1.1. Tissue processing
10.4.3.1.2. Staining
10.4.3.1.3. Immunohistochemistry
10.4.3.1.4. Pathology evaluation
10.4.3.1.5. Slide preparation and evaluation
10.4.3.1.6. Others
10.4.3.2. Mexico Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
10.4.3.2.1. Research Centers
10.4.3.2.2. Hospitals and Clinics
10.4.3.2.3. Pharmaceutical Companies
10.4.3.2.4. Others
10.4.4. Rest of North America
10.4.4.1. Rest of North America Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
10.4.4.1.1. Tissue processing
10.4.4.1.2. Staining
10.4.4.1.3. Immunohistochemistry
10.4.4.1.4. Pathology evaluation
10.4.4.1.5. Slide preparation and evaluation
10.4.4.1.6. Others
10.4.4.2. Rest of North America Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By End Users
10.4.4.2.1. Research Centers
10.4.4.2.2. Hospitals and Clinics
10.4.4.2.3. Pharmaceutical Companies
10.4.4.2.4. Others
10.5. Key Segment for Channeling Investments
10.5.1. By Country
10.5.2. By Service Type
10.5.3. By End Users
11. Europe Histopathology Services Market
Analysis and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. Europe Histopathology Services Market Revenue
(US$ Mn)
11.2. Europe Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
11.2.1. Tissue processing
11.2.2. Staining
11.2.3. Immunohistochemistry
11.2.4. Pathology evaluation
11.2.5. Slide preparation and evaluation
11.2.6. Others
11.3. Europe Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
11.3.1. Research Centers
11.3.2. Hospitals and Clinics
11.3.3. Pharmaceutical Companies
11.3.4. Others
11.4. Europe Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1. France Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
11.4.1.1.1. Tissue processing
11.4.1.1.2. Staining
11.4.1.1.3. Immunohistochemistry
11.4.1.1.4. Pathology evaluation
11.4.1.1.5. Slide preparation and evaluation
11.4.1.1.6. Others
11.4.1.2. France Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
11.4.1.2.1. Research Centers
11.4.1.2.2. Hospitals and Clinics
11.4.1.2.3. Pharmaceutical Companies
11.4.1.2.4. Others
11.4.2. The UK
11.4.2.1. The UK Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
11.4.2.1.1. Tissue processing
11.4.2.1.2. Staining
11.4.2.1.3. Immunohistochemistry
11.4.2.1.4. Pathology evaluation
11.4.2.1.5. Slide preparation and evaluation
11.4.2.1.6. Others
11.4.2.2. The UK Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
11.4.2.2.1. Research Centers
11.4.2.2.2. Hospitals and Clinics
11.4.2.2.3. Pharmaceutical Companies
11.4.2.2.4. Others
11.4.3. Spain
11.4.3.1. Spain Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
11.4.3.1.1. Tissue processing
11.4.3.1.2. Staining
11.4.3.1.3. Immunohistochemistry
11.4.3.1.4. Pathology evaluation
11.4.3.1.5. Slide preparation and evaluation
11.4.3.1.6. Others
11.4.3.2. Spain Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
11.4.3.2.1. Research Centers
11.4.3.2.2. Hospitals and Clinics
11.4.3.2.3. Pharmaceutical Companies
11.4.3.2.4. Others
11.4.4. Germany
11.4.4.1. Germany Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.4.1.1. Tissue processing
11.4.4.1.2. Staining
11.4.4.1.3. Immunohistochemistry
11.4.4.1.4. Pathology evaluation
11.4.4.1.5. Slide preparation and evaluation
11.4.4.1.6. Others
11.4.4.2. Germany Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.4.2.1. Research Centers
11.4.4.2.2. Hospitals and Clinics
11.4.4.2.3. Pharmaceutical Companies
11.4.4.2.4. Others
11.4.5. Italy
11.4.5.1. Italy Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
11.4.5.1.1. Tissue processing
11.4.5.1.2. Staining
11.4.5.1.3. Immunohistochemistry
11.4.5.1.4. Pathology evaluation
11.4.5.1.5. Slide preparation and evaluation
11.4.5.1.6. Others
11.4.5.2. Italy Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
11.4.5.2.1. Research Centers
11.4.5.2.2. Hospitals and Clinics
11.4.5.2.3. Pharmaceutical Companies
11.4.5.2.4. Others
11.4.6. Nordic Countries
11.4.6.1. Nordic Countries Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
11.4.6.1.1. Tissue processing
11.4.6.1.2. Staining
11.4.6.1.3. Immunohistochemistry
11.4.6.1.4. Pathology evaluation
11.4.6.1.5. Slide preparation and evaluation
11.4.6.1.6. Others
11.4.6.2. Nordic Countries Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.6.2.1. Research Centers
11.4.6.2.2. Hospitals and Clinics
11.4.6.2.3. Pharmaceutical Companies
11.4.6.2.4. Others
11.4.6.3. Nordic Countries Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux Union
11.4.7.1. Benelux Union Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.7.1.1. Tissue processing
11.4.7.1.2. Staining
11.4.7.1.3. Immunohistochemistry
11.4.7.1.4. Pathology evaluation
11.4.7.1.5. Slide preparation and evaluation
11.4.7.1.6. Others
11.4.7.2. Benelux Union Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.7.2.1. Research Centers
11.4.7.2.2. Hospitals and Clinics
11.4.7.2.3. Pharmaceutical Companies
11.4.7.2.4. Others
11.4.7.3. Benelux Union Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of Europe
11.4.8.1. Rest of Europe Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
11.4.8.1.1. Tissue processing
11.4.8.1.2. Staining
11.4.8.1.3. Immunohistochemistry
11.4.8.1.4. Pathology evaluation
11.4.8.1.5. Slide preparation and evaluation
11.4.8.1.6. Others
11.4.8.2. Rest of Europe Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.8.2.1. Research Centers
11.4.8.2.2. Hospitals and Clinics
11.4.8.2.3. Pharmaceutical Companies
11.4.8.2.4. Others
11.5. Key Segment for Channeling Investments
11.5.1. By Country
11.5.2. By Service Type
11.5.3. By End Users
12. Asia Pacific Histopathology Services Market
Analysis and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Asia Pacific Histopathology Services Market
Revenue (US$ Mn)
12.2. Asia Pacific Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.2.1. Tissue processing
12.2.2. Staining
12.2.3. Immunohistochemistry
12.2.4. Pathology evaluation
12.2.5. Slide preparation and evaluation
12.2.6. Others
12.3. Asia Pacific Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.3.1. Research Centers
12.3.2. Hospitals and Clinics
12.3.3. Pharmaceutical Companies
12.3.4. Others
12.4. Asia Pacific Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Country
12.4.1. China
12.4.1.1. China Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
12.4.1.1.1. Tissue processing
12.4.1.1.2. Staining
12.4.1.1.3. Immunohistochemistry
12.4.1.1.4. Pathology evaluation
12.4.1.1.5. Slide preparation and evaluation
12.4.1.1.6. Others
12.4.1.2. China Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
12.4.1.2.1. Research Centers
12.4.1.2.2. Hospitals and Clinics
12.4.1.2.3. Pharmaceutical Companies
12.4.1.2.4. Others
12.4.2. Japan
12.4.2.1. Japan Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
12.4.2.1.1. Tissue processing
12.4.2.1.2. Staining
12.4.2.1.3. Immunohistochemistry
12.4.2.1.4. Pathology evaluation
12.4.2.1.5. Slide preparation and evaluation
12.4.2.1.6. Others
12.4.2.2. Japan Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
12.4.2.2.1. Research Centers
12.4.2.2.2. Hospitals and Clinics
12.4.2.2.3. Pharmaceutical Companies
12.4.2.2.4. Others
12.4.3. India
12.4.3.1. India Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
12.4.3.1.1. Tissue processing
12.4.3.1.2. Staining
12.4.3.1.3. Immunohistochemistry
12.4.3.1.4. Pathology evaluation
12.4.3.1.5. Slide preparation and evaluation
12.4.3.1.6. Others
12.4.3.2. India Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
12.4.3.2.1. Research Centers
12.4.3.2.2. Hospitals and Clinics
12.4.3.2.3. Pharmaceutical Companies
12.4.3.2.4. Others
12.4.4. New Zealand
12.4.4.1. New Zealand Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.4.1.1. Tissue processing
12.4.4.1.2. Staining
12.4.4.1.3. Immunohistochemistry
12.4.4.1.4. Pathology evaluation
12.4.4.1.5. Slide preparation and evaluation
12.4.4.1.6. Others
12.4.4.2. New Zealand Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
12.4.4.2.1. Research Centers
12.4.4.2.2. Hospitals and Clinics
12.4.4.2.3. Pharmaceutical Companies
12.4.4.2.4. Others
12.4.5. Australia
12.4.5.1. Australia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.5.1.1. Tissue processing
12.4.5.1.2. Staining
12.4.5.1.3. Immunohistochemistry
12.4.5.1.4. Pathology evaluation
12.4.5.1.5. Slide preparation and evaluation
12.4.5.1.6. Others
12.4.5.2. Australia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.5.2.1. Research Centers
12.4.5.2.2. Hospitals and Clinics
12.4.5.2.3. Pharmaceutical Companies
12.4.5.2.4. Others
12.4.6. South Korea
12.4.6.1. South Korea Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.6.1.1. Tissue processing
12.4.6.1.2. Staining
12.4.6.1.3. Immunohistochemistry
12.4.6.1.4. Pathology evaluation
12.4.6.1.5. Slide preparation and evaluation
12.4.6.1.6. Others
12.4.6.2. South Korea Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.6.2.1. Research Centers
12.4.6.2.2. Hospitals and Clinics
12.4.6.2.3. Pharmaceutical Companies
12.4.6.2.4. Others
12.4.7. Southeast Asia
12.4.7.1. Southeast Asia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
12.4.7.1.1. Tissue processing
12.4.7.1.2. Staining
12.4.7.1.3. Immunohistochemistry
12.4.7.1.4. Pathology evaluation
12.4.7.1.5. Slide preparation and evaluation
12.4.7.1.6. Others
12.4.7.2. Southeast Asia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.7.2.1. Research Centers
12.4.7.2.2. Hospitals and Clinics
12.4.7.2.3. Pharmaceutical Companies
12.4.7.2.4. Others
12.4.7.3. Southeast Asia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest of Southeast Asia
12.4.8. Rest of Asia Pacific
12.4.8.1. Rest of Asia Pacific Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
12.4.8.1.1. Tissue processing
12.4.8.1.2. Staining
12.4.8.1.3. Immunohistochemistry
12.4.8.1.4. Pathology evaluation
12.4.8.1.5. Slide preparation and evaluation
12.4.8.1.6. Others
12.4.8.2. Rest of Asia Pacific Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.8.2.1. Research Centers
12.4.8.2.2. Hospitals and Clinics
12.4.8.2.3. Pharmaceutical Companies
12.4.8.2.4. Others
12.5. Key Segment for Channeling Investments
12.5.1. By Country
12.5.2. By Service Type
12.5.3. By End Users
13. Middle East and Africa Histopathology
Services Market Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Middle East and Africa Histopathology Services
Market Revenue (US$ Mn)
13.2. Middle East and Africa Histopathology
Services Market Revenue (US$ Mn) and Forecasts, By Service Type
13.2.1. Tissue processing
13.2.2. Staining
13.2.3. Immunohistochemistry
13.2.4. Pathology evaluation
13.2.5. Slide preparation and evaluation
13.2.6. Others
13.3. Middle East and Africa Histopathology
Services Market Revenue (US$ Mn) and Forecasts, By End Users
13.3.1. Research Centers
13.3.2. Hospitals and Clinics
13.3.3. Pharmaceutical Companies
13.3.4. Others
13.4. Middle East and Africa Histopathology
Services Market Revenue (US$ Mn) and Forecasts, By Country
13.4.1. Saudi Arabia
13.4.1.1. Saudi Arabia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
13.4.1.1.1. Tissue processing
13.4.1.1.2. Staining
13.4.1.1.3. Immunohistochemistry
13.4.1.1.4. Pathology evaluation
13.4.1.1.5. Slide preparation and evaluation
13.4.1.1.6. Others
13.4.1.2. Saudi Arabia Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
13.4.1.2.1. Research Centers
13.4.1.2.2. Hospitals and Clinics
13.4.1.2.3. Pharmaceutical Companies
13.4.1.2.4. Others
13.4.2. UAE
13.4.2.1. UAE Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
13.4.2.1.1. Tissue processing
13.4.2.1.2. Staining
13.4.2.1.3. Immunohistochemistry
13.4.2.1.4. Pathology evaluation
13.4.2.1.5. Slide preparation and evaluation
13.4.2.1.6. Others
13.4.2.2. UAE Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
13.4.2.2.1. Research Centers
13.4.2.2.2. Hospitals and Clinics
13.4.2.2.3. Pharmaceutical Companies
13.4.2.2.4. Others
13.4.3. Egypt
13.4.3.1. Egypt Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
13.4.3.1.1. Tissue processing
13.4.3.1.2. Staining
13.4.3.1.3. Immunohistochemistry
13.4.3.1.4. Pathology evaluation
13.4.3.1.5. Slide preparation and evaluation
13.4.3.1.6. Others
13.4.3.2. Egypt Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
13.4.3.2.1. Research Centers
13.4.3.2.2. Hospitals and Clinics
13.4.3.2.3. Pharmaceutical Companies
13.4.3.2.4. Others
13.4.4. Kuwait
13.4.4.1. Kuwait Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
13.4.4.1.1. Tissue processing
13.4.4.1.2. Staining
13.4.4.1.3. Immunohistochemistry
13.4.4.1.4. Pathology evaluation
13.4.4.1.5. Slide preparation and evaluation
13.4.4.1.6. Others
13.4.4.2. Kuwait Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
13.4.4.2.1. Research Centers
13.4.4.2.2. Hospitals and Clinics
13.4.4.2.3. Pharmaceutical Companies
13.4.4.2.4. Others
13.4.5. South Africa
13.4.5.1. South Africa Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
13.4.5.1.1. Tissue processing
13.4.5.1.2. Staining
13.4.5.1.3. Immunohistochemistry
13.4.5.1.4. Pathology evaluation
13.4.5.1.5. Slide preparation and evaluation
13.4.5.1.6. Others
13.4.5.2. South Africa Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
13.4.5.2.1. Research Centers
13.4.5.2.2. Hospitals and Clinics
13.4.5.2.3. Pharmaceutical Companies
13.4.5.2.4. Others
13.4.6. Rest of Middle East & Africa
13.4.6.1. Rest of Middle East & Africa
Histopathology Services Market Revenue (US$ Mn) and Forecasts, By Service Type
13.4.6.1.1. Tissue processing
13.4.6.1.2. Staining
13.4.6.1.3. Immunohistochemistry
13.4.6.1.4. Pathology evaluation
13.4.6.1.5. Slide preparation and evaluation
13.4.6.1.6. Others
13.4.6.2. Rest of Middle East & Africa
Histopathology Services Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.6.2.1. Research Centers
13.4.6.2.2. Hospitals and Clinics
13.4.6.2.3. Pharmaceutical Companies
13.4.6.2.4. Others
13.5. Key Segment for Channeling Investments
13.5.1. By Country
13.5.2. By Service Type
13.5.3. By End Users
14. Latin America Histopathology Services Market
Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Latin America Histopathology Services Market
Revenue (US$ Mn)
14.2. Latin America Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
14.2.1. Tissue processing
14.2.2. Staining
14.2.3. Immunohistochemistry
14.2.4. Pathology evaluation
14.2.5. Slide preparation and evaluation
14.2.6. Others
14.3. Latin America Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
14.3.1. Research Centers
14.3.2. Hospitals and Clinics
14.3.3. Pharmaceutical Companies
14.3.4. Others
14.4. Latin America Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Country
14.4.1. Brazil
14.4.1.1. Brazil Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By Service Type
14.4.1.1.1. Tissue processing
14.4.1.1.2. Staining
14.4.1.1.3. Immunohistochemistry
14.4.1.1.4. Pathology evaluation
14.4.1.1.5. Slide preparation and evaluation
14.4.1.1.6. Others
14.4.1.2. Brazil Histopathology Services Market Revenue
(US$ Mn) and Forecasts, By End Users
14.4.1.2.1. Research Centers
14.4.1.2.2. Hospitals and Clinics
14.4.1.2.3. Pharmaceutical Companies
14.4.1.2.4. Others
14.4.2. Argentina
14.4.2.1. Argentina Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By Service Type
14.4.2.1.1. Tissue processing
14.4.2.1.2. Staining
14.4.2.1.3. Immunohistochemistry
14.4.2.1.4. Pathology evaluation
14.4.2.1.5. Slide preparation and evaluation
14.4.2.1.6. Others
14.4.2.2. Argentina Histopathology Services Market
Revenue (US$ Mn) and Forecasts, By End Users
14.4.2.2.1. Research Centers
14.4.2.2.2. Hospitals and Clinics
14.4.2.2.3. Pharmaceutical Companies
14.4.2.2.4. Others
14.4.3. Rest of Latin America
14.4.3.1. Rest of Latin America Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By Service Type
14.4.3.1.1. Tissue processing
14.4.3.1.2. Staining
14.4.3.1.3. Immunohistochemistry
14.4.3.1.4. Pathology evaluation
14.4.3.1.5. Slide preparation and evaluation
14.4.3.1.6. Others
14.4.3.2. Rest of Latin America Histopathology Services
Market Revenue (US$ Mn) and Forecasts, By End Users
14.4.3.2.1. Research Centers
14.4.3.2.2. Hospitals and Clinics
14.4.3.2.3. Pharmaceutical Companies
14.4.3.2.4. Others
14.5. Key Segment for Channeling Investments
14.5.1. By Country
14.5.2. By Service Type
14.5.3. By End Users
15. Competitive Benchmarking
15.1. Brand Benchmarking
15.2. Market Share Analysis, 2020
15.3. Global Presence and Growth Strategies
15.3.1. Mergers and Acquisitions
15.3.2. Product Launches
15.3.3. Investments Trends
15.3.4. R&D Initiatives
16. Player Profiles
16.1. AnaPath Services GmbH
16.1.1. Company Details
16.1.2. Company Overview
16.1.3. Product Offerings
16.1.4. Key Developments
16.1.5. Financial Analysis
16.1.6. SWOT Analysis
16.1.7. Business Strategies
16.2. BioIVT LLC.
16.2.1. Company Details
16.2.2. Company Overview
16.2.3. Product Offerings
16.2.4. Key Developments
16.2.5. Financial Analysis
16.2.6. SWOT Analysis
16.2.7. Business Strategies
16.3. CellCarta
16.3.1. Company Details
16.3.2. Company Overview
16.3.3. Product Offerings
16.3.4. Key Developments
16.3.5. Financial Analysis
16.3.6. SWOT Analysis
16.3.7. Business Strategies
16.4. Cellular Pathology Services Limited
16.4.1. Company Details
16.4.2. Company Overview
16.4.3. Product Offerings
16.4.4. Key Developments
16.4.5. Financial Analysis
16.4.6. SWOT Analysis
16.4.7. Business Strategies
16.5. Comparative Biosciences, Inc.
16.5.1. Company Details
16.5.2. Company Overview
16.5.3. Product Offerings
16.5.4. Key Developments
16.5.5. Financial Analysis
16.5.6. SWOT Analysis
16.5.7. Business Strategies
16.6. Core Diagnostics, HistologiX Limited
16.6.1. Company Details
16.6.2. Company Overview
16.6.3. Product Offerings
16.6.4. Key Developments
16.6.5. Financial Analysis
16.6.6. SWOT Analysis
16.6.7. Business Strategies
16.7. Histopathology Services Inc.
16.7.1. Company Details
16.7.2. Company Overview
16.7.3. Product Offerings
16.7.4. Key Developments
16.7.5. Financial Analysis
16.7.6. SWOT Analysis
16.7.7. Business Strategies
16.8. Liveon Biolabs Pvt.Ltd.
16.8.1. Company Details
16.8.2. Company Overview
16.8.3. Product Offerings
16.8.4. Key Developments
16.8.5. Financial Analysis
16.8.6. SWOT Analysis
16.8.7. Business Strategies
16.9. MLM Medical Labs GmbH
16.9.1. Company Details
16.9.2. Company Overview
16.9.3. Product Offerings
16.9.4. Key Developments
16.9.5. Financial Analysis
16.9.6. SWOT Analysis
16.9.7. Business Strategies
16.10. Molecular Diagnostic Services, Inc.
16.10.1. Company Details
16.10.2. Company Overview
16.10.3. Product Offerings
16.10.4. Key Developments
16.10.5. Financial Analysis
16.10.6. SWOT Analysis
16.10.7. Business Strategies
16.11. Pathology Services Core
16.11.1. Company Details
16.11.2. Company Overview
16.11.3. Product Offerings
16.11.4. Key Developments
16.11.5. Financial Analysis
16.11.6. SWOT Analysis
16.11.7. Business Strategies
16.12. Q2 Solutions
16.12.1. Company Details
16.12.2. Company Overview
16.12.3. Product Offerings
16.12.4. Key Developments
16.12.5. Financial Analysis
16.12.6. SWOT Analysis
16.12.7. Business Strategies
16.13. Saffron Scientific Histology Services
16.13.1. Company Details
16.13.2. Company Overview
16.13.3. Product Offerings
16.13.4. Key Developments
16.13.5. Financial Analysis
16.13.6. SWOT Analysis
16.13.7. Business Strategies
16.14. Suburban Diagnostics
16.14.1. Company Details
16.14.2. Company Overview
16.14.3. Product Offerings
16.14.4. Key Developments
16.14.5. Financial Analysis
16.14.6. SWOT Analysis
16.14.7. Business Strategies
16.15. The Doctors Laboratory
16.15.1. Company Details
16.15.2. Company Overview
16.15.3. Product Offerings
16.15.4. Key Developments
16.15.5. Financial Analysis
16.15.6. SWOT Analysis
16.15.7. Business Strategies
16.16. TOXIKON
16.16.1. Company Details
16.16.2. Company Overview
16.16.3. Product Offerings
16.16.4. Key Developments
16.16.5. Financial Analysis
16.16.6. SWOT Analysis
16.16.7. Business Strategies
16.17. Other Market Participants
17. Key Findings
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.